545 related articles for article (PubMed ID: 29487568)
21. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
[TBL] [Abstract][Full Text] [Related]
22. Hwanggeumchal sorghum extract enhances BMP7 and GH signaling through the activation of Jak2/STAT5B in MC3T3‑E1 osteoblastic cells.
Joung YH; Lim EJ; Darvin P; Jang JW; Park KD; Lee HK; Kim HS; Cho BW; Park T; Chung S; Park JH; Yang YM
Mol Med Rep; 2013 Sep; 8(3):891-6. PubMed ID: 23877734
[TBL] [Abstract][Full Text] [Related]
23. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
24. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
[TBL] [Abstract][Full Text] [Related]
27. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
28. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA; Waxman DJ
J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
[TBL] [Abstract][Full Text] [Related]
29. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.
Schaefer F; Chen Y; Tsao T; Nouri P; Rabkin R
J Clin Invest; 2001 Aug; 108(3):467-75. PubMed ID: 11489940
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
31. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
Rui H; Xu J; Mehta S; Fang H; Williams J; Dong F; Grimley PM
J Biol Chem; 1998 Jan; 273(1):28-32. PubMed ID: 9417042
[TBL] [Abstract][Full Text] [Related]
32. Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
Wiezel D; Assadi MH; Landau D; Troib A; Kachko L; Rabkin R; Segev Y
Nephrol Dial Transplant; 2014 Apr; 29(4):791-9. PubMed ID: 24463190
[TBL] [Abstract][Full Text] [Related]
33. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
35. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
[TBL] [Abstract][Full Text] [Related]
36. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues.
Deng L; Jiang J; Frank SJ
Endocrinology; 2012 May; 153(5):2311-22. PubMed ID: 22416081
[TBL] [Abstract][Full Text] [Related]
38. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
Stofega MR; Herrington J; Billestrup N; Carter-Su C
Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
40. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.
Wang L; Kurosaki T; Corey SJ
Oncogene; 2007 May; 26(20):2851-9. PubMed ID: 17146444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
